Artificial Intelligence (AI) is changing the future of all industries, but findings published today by intellectual property firm, Marks & Clerk, reveal the medical technology (medtech) sector is surging ahead. The number of AI-based patent applications filed by the sector has almost quadrupled since 2018 to 2771 medtech publications in 2022. But most strikingly, as a standalone sector, the year-on-year percentage growth in the number of AI applications filed repeatedly surpassed that of overall AI between 2014 and 2021.

Alignment with U.S. FDA on design of Phase 2/3 registrational trial, to be initiated in 1Q 2024

Innovative study design allows for potential accelerated approval in untreated (first-line) and previously treated (second-line plus) metastatic bladder cancer

Conference call and webcast today at 8 a.m. ET

Zurich, Switzerland and Cambridge, UK, September 2023 – Biotechgate, a leading global life sciences business development and licensing database and One Nucleus, a Cambridge, UK-based life sciences and healthcare membership organisation, are thrilled to announce a collaboration to boost life sciences connectivity and innovation. The purpose of this collaboration is to provide a reliable hub of information for professionals, organizations, and individuals across the industry by enhancing connections and promoting innovation.

Huge congratulations to Dr Sally Ann Forsyth OBE, CEO, Stevenage Bioscience Catalyst, who has been awarded an Honorary Doctorate from the University of Hertfordshire in recognition of her lifetime achievements in science, on Tuesday 5 September at the start of the University of Hertfordshire’s annual graduation ceremony taking place over two weeks at St Albans Cathedral.

Strengthens supply chain for AqFresh™ air quality technology, as demand growsNew modular system designed for straight-forward integration into manufacturers’ existing plantsCements partnership between Aqdot and Menadiona

One Nucleus member, Appleyard Lees LLP, is a leading intellectual property firm supporting their clients to protect and monetise their IP, and manage post-grant challenges that could arise. 

Recently, team members at Appleyard Lees shared some interesting insights into: 

  • Partnership to provide customers with direct access to portfolio of highly characterized hepatic cells to recreate advanced Liver-on-a-Chip assays

  • Pre-validated cells alleviate the need for stringent in-house quality control testing to maximize assay success


AMSBIO has supplied a custom monoclonal antibody (mAB) to researchers at the TU Dortmund** in Germany to unravel the role of EDI3 in breast cancer development, its regulation by HER2 signalling, and its potential as a therapeutic target.

Did you know...

  • Ireland's life sciences sector exports more than 45 billion Euros annually and employs over 50,000 people?

  • All but one of the world's 25 largest biotech and pharma companies have a presence in Ireland?

  • Ireland is the world's third largest exporter of pharmaceuticals and has over 50 FDA approved pharma and biopharma plants?

What can Biocair and Aramex Ireland do to support you?

BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced that it will be showcasing its newly expanded ADME-Tox research capabilities at the 25th North American International Society for the Study of Xenobiotics (ISSX) Meeting, which will be held from September 10-13 in Boston, MA.